iMEAN
PrivateLast Round
Grant
Jul 9, 2020
Momentum Score
50 /100
Company Overview
iMEAN is a biotechnology company that provides R&D support services using digital organisms and mathematical modeling for the agriculture, industrial biotechnology, and healthcare sectors.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, ML Platforms, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iMEAN Comps
Public and private peers based on sector, stage, and business model.
iMEAN Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2020 | ||||
| Accelerator | Sep 3, 2018 |
Key People
Founding team and executive leadership
iMEAN Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Région Occitanie | Grant |
| French Ministry of the Economy, Finance and Industrial and Digital Sovereignty | Grant |
| Bpifrance | Grant |
| Nubbo | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2026
Grew 18% QoQ, from 17 to 20 employees.
- Jul 9, 2020
Received grant funding from Bpifrance and other French entities.
iMEAN Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iMEAN's valuation, stock price, and market status.
